About Andrew Kay
Andrew Kay is a director at AdvanCell.
Experience
This experience comes from Andrew Kay's profile and from SEC filings. For roles taken from filings, the years are when the filings name Andrew Kay in the role, so the role may have started earlier or lasted longer.
AdvanCell, Inc. Current
Chairman of the Board of Directors
2025 – Present · Cambridge, MA
Develops targeted radiation treatments for people with cancer.
NP
NuCana plc Current
Chairman Of The Board
2020 – Present
AL
Amulet Consulting Ltd Current
Chairman, Board Advisor and Consultant - Pharmaceuticals and Biotech
2014 – Present
WL
WalkSafe Ltd.
Chairman and Director
2021 – 2026
NL
NERRE THERAPEUTICS LTD
Chairman Of The Board
2017 – 2026
BL
Blueberry Therapeutics Ltd
Chairman Of The Board
2015 – 2023
KT
KaNDy Therapeutics
Chairman Of The Board
2019 – 2020
WT
Wilson Therapeutics
Chairman Of The Board
2015 – 2018
AA
Algeta ASA
President and CEO - Biotech
2009 – 2014
RE
Renovo
Main Board Director & Executive Commercial Director - (COO) Biotech
2003 – 2009
NO
Novartis
Head Global Marketing and Sales- Pharmaceutical Executive Team
1999 – 2003
AS
AstraZeneca
Head of Business Management Dept - Region Europe
1997 – 1999
ZP
Zeneca Pharmaceuticals
Head Zeneca Diagnostics
1989 – 1999
EC
Eli Lilly and Company
International Marketing
1982 – 1985
Key Colleagues at Startups
The people Andrew Kay works with at each company, as listed on that company's latest Form D.
AdvanCell, Inc. · Form D, Jul 16, 2026
PL
Philina Lee
Chief Executive Officer and director
JB
Jamil Beg
Director
KC
Kevin Cameron
Director
CG
Christopher Gagliardi
Director
BM
Bali Muralidhar
Director
WL
Wing Cheong Lam
Director
AA
Andrew Adamovich
Founder & Managing Director, Australia
AP
Aaron Pickett
Secretary
NE
Nik Economopoulos
Director
AA
Anthony Aiudi
Director